Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/14/2005CN1706387A Stable cephalosporin powder injection
12/14/2005CN1706386A Enrofloxacin suspension and its prepn process
12/14/2005CN1706385A New composition for treating seasonal and perennial allergic rhinitis
12/14/2005CN1706384A Prepn process of compound hydrocodone tablet
12/14/2005CN1706383A Dispersant rotundine tablet and its prepn process
12/14/2005CN1706382A New use of atebrine
12/14/2005CN1706381A Frostbite and chilblain treating ointment
12/14/2005CN1706380A Kararinol tablet and its production process
12/14/2005CN1706379A Antibiotic composition for injection
12/14/2005CN1706378A Composition for treating inflammation which contains zinc pyrrolidonecarboxylate
12/14/2005CN1706377A Norcantharidin emulsion capable of being sterilized through filtering and its prepn process
12/14/2005CN1706376A Application of garcinolic acid in preparing medicine for treating tumor metastasis
12/14/2005CN1706375A Application of total garcinolic acid in preparing medicine for treating tumor metastasis
12/14/2005CN1706374A Solid tumor treating medicine composition
12/14/2005CN1706373A Orally disintegrated Ubenimex tablet and its prepn process
12/14/2005CN1706372A Orally disintegrated sodium ferulate tablet and its prepn process
12/14/2005CN1706371A Efficient sword-like iris seed prepn and its prepn process
12/14/2005CN1706370A Lipid microspherical asarol prepn and its prepn process
12/14/2005CN1706369A Sequoyitol and sequoyitol extract for preventing and treating diabetes
12/14/2005CN1706368A Mouse steriliant and its prepn process
12/14/2005CN1231578C Attenuated virus of ox's viral diarrhea
12/14/2005CN1231493C Amphoteric sterols and the use thereof
12/14/2005CN1231490C Erythromycin derivative having novel crystal structures and process for their production
12/14/2005CN1231484C Benzo [b] pyran-[3,2-h] acridinyl-7-one compounds, their prepn and medicine composition containing them
12/14/2005CN1231483C 8-Azabicyclo [3.,2.1] Oct-2-Ene and-Octane derivatives
12/14/2005CN1231482C Processes for the preparation of thiazolidinedione derivatives and intermediates
12/14/2005CN1231479C Naphthostyrils compounds
12/14/2005CN1231477C Potassium salt of (I(S))-omeprazole
12/14/2005CN1231474C Salts of aiso thiazole-4-carboxamide and their use as anti-hyperproliferatin agents
12/14/2005CN1231473C Substituted arylpyrazines
12/14/2005CN1231472C Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
12/14/2005CN1231471C 4-amino-5-cyano-2-anilino-pyrimidine derivatives and their use as inhbitors of cell-cycle kinases
12/14/2005CN1231468C Chemical compounds
12/14/2005CN1231467C High affinity ligands for nociceptin receptor ORL-1
12/14/2005CN1231466C New piperidine derivatives
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof
12/14/2005CN1231461C Bicyclo [2.2.1] heptanes and related compounds
12/14/2005CN1231460C Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof
12/14/2005CN1231459C Novel aminobenzophenones
12/14/2005CN1231458C Novel aryloxy-alkyl-dialkylamines compound
12/14/2005CN1231457C Substituted cycloheptaene and its preparation process and use
12/14/2005CN1231440C Novel tricyclic compound
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/14/2005CN1231264C Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan
12/14/2005CN1231225C Application of Artemisia sphaerocephala Krasch polysaccharide in preparation of antilipemic agent and health products
12/14/2005CN1231224C Sealwort polysaccharide konjaku glucomannan capsule
12/14/2005CN1231223C Breviscapine infusion preparation and its preparing method
12/14/2005CN1231222C Application of Funaosu in preventing and treating cadiovascular and cerebrovascular diseases
12/14/2005CN1231221C Process for producing Liposome injection liquid of hydrochloric acid daunerubicin
12/14/2005CN1231220C New use of verbascum glycoside
12/14/2005CN1231219C Huangyangning slow-releasing preparation
12/14/2005CN1231218C Use of medicinal composition in preparing medicine for treating middle ear infections
12/14/2005CN1231217C Medicine for treating climacteric syndrome
12/14/2005CN1231216C Aspartic acid lomefloxacin powder and preparing method thereof
12/14/2005CN1231215C (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/14/2005CN1231214C 5HT2 agonists for controlling IOP and treating glaucoma
12/14/2005CN1231213C Sobering-up liver-protecting composition and preparation thereof
12/14/2005CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4
12/14/2005CN1231210C Progesterone capsule composition and preparation thereof
12/14/2005CN1231209C Ursolic acid poly lactic acid nano particle freeze dried powder injection and its preparation method
12/14/2005CA2509007A1 Agents for producing the health-benefits of repeated exercise
12/14/2005CA2471219A1 Improved preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride)
12/13/2005USRE38921 have strong and selective leukotriene antagonist activity, and are useful for prevention and treatment of allergic diseases such as bronchial asthma
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/13/2005US6974872 Process for production of piperidine derivatives
12/13/2005US6974870 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/13/2005US6974868 A 6-(7-((2-(phenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2, 3-triazolo(4,5-d)pyrimidin-3-yl)-tetrahydro-2,2-dimethyl-4H-cyclopentane-1,2-diol derivative; anticoagulants; myocardial infarction, strokes; thrombolytic and antiischemic agents;
12/13/2005US6974867 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/13/2005US6974840 Therapeutic agents
12/13/2005US6974839 Method of delaying ejaculation
12/13/2005US6974838 dopamine reuptake inhibitors; for treatment of thoratic outlet obstruction syndrome
12/13/2005US6974837 Compositions comprising sibutramine metabolites in combination with phosphodiesterase inhibitors
12/13/2005US6974836 Diamines as modulators of chemokine receptor activity
12/13/2005US6974835 Use of cannabinoid compounds for cancer therapy
12/13/2005US6974833 Particularly atheriosclerosis, cancer, infection or other inflammatory diseases
12/13/2005US6974832 L-ascorbic acid and pectin composition
12/13/2005US6974831 sPLA2 inhibitors
12/13/2005US6974830 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
12/13/2005US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders
12/13/2005US6974826 such as 3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-4-methoxybenzylidene-2,4-thiazolidinedione; Hodgkin's disease
12/13/2005US6974825 piperidines or pyrroles with an amido- or sulfonamidophenylamino group; reductive amination of a piperidone with a substituted arylamine then further arylation; ligand for the delta opiod receptor; less side effects than current mu agonists; oral
12/13/2005US6974824 N-substituted-4-(m-hydroxyphenyl)piperidine derivated and esters thereof, used to bind a kappa opioid receptor; treating drug addiction
12/13/2005US6974823 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same
12/13/2005US6974821 Methods for treating neuropsychiatric disorders
12/13/2005US6974820 Methods for treating urinary incontinence and other disorders using trospium
12/13/2005US6974819 Alzheimer's disease; Parkinson's disease; Pick's disease; bipolar disorders; schizophrenia; alopecia; anticancer agents
12/13/2005US6974818 1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
12/13/2005US6974817 CCR1 receptor antagonists; inhibitors of MIP-1 alpha (CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells; macrophage inflammatory protein (MIP)
12/13/2005US6974815 effective as antagonists of Leukointegrins and/or ICAMs
12/13/2005US6974814 Via administration of agents that possess glutamate-related and/or glycine-related pharmacological activity or that modulate the release of glutamate, glycine, or both from nerve terminals with the central nervous system
12/13/2005US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans
12/13/2005US6974812 such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders (rheumatoid arthritis)
12/13/2005US6974810 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
12/13/2005US6974808 CRF receptor antagonists and methods relating thereto
12/13/2005US6974807 administering topically to alleviate proliferative skin diease; nontoxic
12/13/2005US6974806 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion
12/13/2005US6974805 Crosslinked mucopolysaccharides; drug delivery; wound healing agent for skin disorders
12/13/2005US6974801 Anticancer agents; Alzheimer's diisease; Parkinson's disease; multiple sclerosis; antiinflammatory agents
12/13/2005US6974800 Formulations comprising an inhibitor of carboxypeptidase U and A thrombin inhibitor